ASCENDIA PHARMACEUTICALS, INC. — Form D

ASCENDIA PHARMACEUTICALS, INC. of NORTH BRUNSWICK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-04. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2025-06-04
• Form: D
• Accession: 0001855888-25-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $2.5M
• Minimum investment: $100K
• Investors: 9
• Date of first sale: 2025-05-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-548014

Issuer

• Name: ASCENDIA PHARMACEUTICALS, INC.
• CIK: 0001855888
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 661 US HIGHWAY ONE UNIT B, NORTH BRUNSWICK, NJ, 08902
• Phone: 7326400058

Officers, directors & promoters (13)

Other filings by this issuer (4)

More

• CIK 1855888 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search